GAVISCON ADVANCE PEPPERMINT FLAVOUR

Adults and children 12 years and over: 5-10 ml after meals and at bedtime (one to two 5 ml measuring spoons).

Children under 12 years:

Should be given only on medical advice.

Elderly:

No dose modification is required for this age group.

Hepatic Impairment:

No dose modification necessary. 4).

Adverse reactions have been ranked under headings of frequency using the following convention: very common (1/10), common (1/100 and <1/10), uncommon (1/1000 and <1/100), rare (1/10,000 and <1/1000), very rare (< 1/10,000) and not known (cannot be estimated from the available data).

System Organ Class Frequency Adverse Event Gastrointestinal Disorders Uncommon Diarrhoea, nausea, vomiting. Immune System Disorders Very rare Anaphylactic and anaphylactoid reactions. Hypersensitivity reactions such as urticaria. Respiratory, Thoracic and Mediastinal Disorders Very rare Respiratory effects such as bronchospasm.

Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

If symptoms do not improve after 7 days, the clinical situation should be reviewed. 9 % of the WHO recommended maximum daily intake for sodium. 14 % of the WHO recommended maximum daily intake for sodium. This product is considered high in sodium.

g. in some cases of congestive heart failure and renal impairment). 06 mg) Potassium per 5 ml. To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet. 0 mmol) of calcium carbonate.

Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi. This medicinal product contains Methyl hydroxybenzoate and Propyl hydroxybenzoate, which may cause allergic reactions (possibly delayed).

4).